Find out how you can mitigate risks when expanding your biotech business internationally in the current tariff and trade ...

Potential US tariffs add urgency to the EU’s pharma regulation debate, balancing industry calls for innovation against ...

The biopharmaceutical industry saw a strong start to 2025, despite ongoing uncertainty around the potential impact of US ...

Indian scientists evaluated two HPV kits, which have now been rolled out as a step forward in combating cervical cancer, the ...

The sector has grown from its early days of molecule discoveries into an ecosystem that includes biotech, medical devices, ...

Eli Lilly sued four telehealth firms, but it is adopting a new legal strategy in its fight against compounded GLP-1s.

Without a carve-out for tariff exceptions for pharmaceuticals, prices will skyrocket for US patients, experts warn.

Half a dozen of the top industry groups representing car manufacturers and dealers have joined forces in an effort to wave ...

Aspen’s share price plummeted by 30% after it warned shareholders that its earnings could significantly decline due to a ...

The European Commission has no plans to withdraw or revise its proposed overhaul of EU pharmaceutical rules, despite mounting ...

Passive income is essential in retirement, but building a dependable stream isn't easy. Fortunately, top-tier dividend stocks ...

The so-called 'Most Favored Nations' rule would set drug pricing for Medicare in line with the prices paid by other nations, ...